Compound information
- Natural Products
- ZC609648
- Molecular Formula
- C18H22N4O3S
- Molecular Weight
- 374.141261564 g/mol
- Structure
-
- IUPAC Name
- [4-(benzenesulfonyl)piperazin-1-yl]-[(1R,2S)-2-(1-methylpyrazol-4-yl)cyclopropyl]methanone
- InChI
- InChI=1S/C18H22N4O3S/c1-20-13-14(12-19-20)16-11-17(16)18(23)21-7-9-22(10-8-21)26(24,25)15-5-3-2-4-6-15/h2-6,12-13,16-17H,7-11H2,1H3/t16-,17-/m1/s1
- InChI Key
- HPGOESLFVZHXHM-IAGOWNOFSA-N
- SMILES
- Cn1cc([C@H]2C[C@H]2C(=O)N2CCN(S(=O)(=O)c3ccccc3)CC2)cn1
- Source
- ZINC000048288011
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 26 | Ring Count | 4 |
| Heteroatom Count | 8 | Rotatable Bond Count | 4 |
| Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
| Topological Polar Surface Area | 75.51 Å2 | LogP | 1.127 |
| LogS | -2.462 | LogD | 1.452 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.02 | Pgp substrate | 0.594 |
| HIA | 0.966 | F20 % | 0.988 |
| F30 % | 0.933 | Caco-2 | -4.937 |
| MDCK | -4.737 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.962 | PPB | 76.637 |
| VD | 0.792 | Fu | 0.749 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.002 | CYP1A2 substrate | 0.551 |
| CYP2A6 substrate | 0.709 | CYP2B6 substrate | 0.634 |
| CYP2C19 inhibitor | 0.237 | CYP2C19 substrate | 0.935 |
| CYP2C8 substrate | 0.761 | CYP2C9 inhibitor | 0.031 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.001 |
| CYP2D6 substrate | 0.941 | CYP2E1 substrate | 0.927 |
| CYP3A4 inhibitor | 0.02 | CYP3A4 substrate | 1.0 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.527 | CL | 6.622 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.068 | Hepatotoxicity | 0.468 |
| Mutagenicity | 0.052 | Rat Oral Acute Toxicity | 0.479 |
| FDAMDD | 0.827 | Skin Sensitization | 0.005 |
| Carcinogenicity | 0.593 | Eye Corrosion | 0.004 |
| Eye Irritation | 0.083 | Respiratory Toxicity | 0.208 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.387 | IGC50 | 2.265 |
| LC50FM | -9.697 | LC50DM | -0.787 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.288 | NR-AR-LBD | 0.351 |
| NR-AhR | 0.024 | NR-Aromatase | 0.264 |
| NR-ER | 0.295 | NR-ER-LBD | 0.366 |
| NR-PPAR-gamma | 0.137 | SR-ARE | 0.126 |
| SR-ATAD5 | 0.284 | SR-HSE | 0.067 |
| SR-MMP | 0.009 | SR-p53 | 0.034 |
Similar covalent drugs
No similar covalent drugs found for this compound.